Market Research Blog

As infected patients experience digestive problems, the demand for alternative food administration sources has risen. This has upticked the deployment of enteral feeding device on an increased frequency. Additionally, vendors are concentrating on strengthening regional distribution networks to ensure uninterrupted supply of equipment to various healthcare settings and organizations.

Demand across the United States, Brazil and India will especially remain strong, given the fact that these are the worst affected countries, providing immense scope for revenue generation to prominent manufacturers.

As healthcare infrastructure has improved, life expectancy has raised its bar. While this is welcome news, the rapidly proliferating geriatric population has also led to increased incidence of age-related ailments, both malignant and non-malignant. Conditions such as cancer, multiple sclerosis, dementia and brain damage have increased multifold.

Anaphylactic shock is the most common chronic disease in Europe and North America region. Allergy UK says, approximately 20% of patients struggle with anaphylactic reaction in Europe. Anaphylactic shock requires adrenaline auto injector devices to be treated. Adrenaline auto injectors are sold under various brands, such as Emerade, Epipen and Jext in the UK. The global auto injectors market was valued at US$ US$ 1,700 Mn, in terms of value, in 2016, according to the latest research by Future Market Insights (FMI). The report on auto injectors further projects significant growth potential with average year-on-year growth rate of 15.1% through 2026.

Auto injectors are an effective mode of administration for intramuscular drugs. User friendly attributes of auto injectors reduce the burden of carrying conventional needles and syringes. However, limited awareness regarding proper use of auto injectors and high price of branded products are some of the important factors curbing the adoption of auto injector devices in emergency applications.

Get a Sample Copy of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1642

Based on research conducted by the McGill University’s Health Centre Research Institute, allergic patients procuring EpiPen for emergency are not actually using the product as quickly as they should. Further, a number of patients visiting the emergency department due to severe anaphylaxis reaction are already administered epinephrine, says the Journal of Allergy and Clinical Immunology.

Failure to use auto injectors at the right time is mainly due to lack of knowledge about signs of anaphylaxis. Such lack of awareness about the disease and product creates significant challenges, in terms of product adoption, for the manufacturers. Apart from higher pricing, limited shelf life of auto-injector pen & under supply of products (Ex. EpiPen) are the major challenges hindering the patient preference for auto injectors in emergency.

Increasing innovations in materials and device functions of auto-injectors are driving the expansion of the auto injector market. In September 2015, Bayer HealthCare reported the launch of Betaconnect- an electronic auto injector for the treatment of relapsing-remitting multiple sclerosis (RRMS). This auto injector offers complete drug dosage for improved compliance and potentially reduce the overall cost. The SHL Group offers a variety of auto injectors that can accommodate changes in injections, such as larger volumes, high viscosity and others. The auto-injector manufacturers are focusing on improving the functionality of auto-injectors to improve disease management and treatment.

Fierce competition in the auto injectors market due to the patient protection act has created an oligopolistic market environment. As a result, brands, such as EpiPen auto-injector, BD Physioject disposable auto injector, etc., have maintained their ranks in the market. However, recent patient expiration and increasing pressure from government bodies will led to reduction in auto injector prices and thus, reduce the profitability for branded manufacturers.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-1642

Generic auto injectors are expected to present high growth opportunities for investors due to growing support from private insurance providers. Insurance services providers are dropping coverage on highly priced auto injectors and covering newly launched half priced generics. Overall revenue from pre-filled syringes is expected to grow during the forecast period due to rising need for targeted and sustained drug delivery. New entrants must comprehensively study the Auto Injectors market to penetrate and sustain in the price sensitive market. The study of the market scenario will provide insights about the business opportunities

FMI has segmented the global auto injector market by product type, indication, distribution channel & regions. In terms of revenues, pre-filled auto injectors will hold substantial market share over the forecast period. On the contrary, the Fillable auto-injectors segment will exhibit limited investment opportunities, in terms of revenue, through 2026.

This FMI report covers some of the key companies operating in the auto injectors market, such as

• Sanofi, Pfizer, Inc.,
• Becton,
• Dickinson and Company,
• Mylan N.V.,
• Novartis AG,
• Janssen Global Services,
• LLC,
• Antares Pharma,
• Amgen Inc.
• Bayer AG, & Eli Lilly and Company.

Buy Complete Report@ https://www.futuremarketinsights.com/checkout/1642

Key Segment

based on product type

• Prefilled Auto-injectors
• Fillable auto-injectors

based on distribution channel

• Traditional sales channels
• hospital pharmacies
• retail pharmacies

based on regions

• North America
• Latin America
• Europe
• Asia Pacific Excluding Japan
• Japan
• MEA

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Sterilants sales will continue rising as focus on maintaining a clean and hygienic environment increases to prevent the spread of infections. Future Market Insights in a new study has predicted the sterilants market to reach US$ 2.31 Bn by 2021. Sterilants are chemical agents that destroy (or irreversibly inactivate) bacteria, fungi, and viruses, including their spores. They are also known as sporicides or sterilizers.

The sterilants market is expected to grow significantly in terms of revenue over the forecast period owing to the rising incidence of infectious disease transmission and surging demand for compatible sterilants. Among products available, the demand for ethylene oxide (EtO) is expected to remain considerably high. It is expected to account for over one-fourth sales in the market.

Get Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-13126

Demand for sterilants is poised to surge especially amid the COVID-19 outbreak. Consecutive waves of the pandemic has put hospitals and healthcare clinics under pressure to efficiently manage a rising footfall of patients. While the healthcare sector is pulling up the sleeves to contain the soaring number of cases infected with the virus, focus on maintaining a clean and hygienic environment is rising as well.

Healthcare organizations are adopting various policies to respond to the pandemic, one of them being increasing investment in sanitization and sterilants to prevent the risk of infection. Consequently, despite supply chain disruptions witnessed amid the crisis, the demand for sterilants will continue rising.

Key Takeaways from Sterilants Market Study

• Global sterilants market is estimated to rise at a CAGR of 5.9% during the forecast period (2021-2031)
• Presence of a sophisticated healthcare infrastructure and willingness to spend on health and hygiene will support sales in the U.S., which will account for 88% of the North America market in 2021
• Despite ongoing restriction to contain pandemic, the U.K. market will continue rising. In 2021 it is expected to register 4.3% y-o-y growth
• Expansion of the healthcare sector will creative conducive environment for growth in India
• Rising disposable income and favorable insurance policies will support the expansion of sterilants market in China

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-13126

 “Competition in the sterilants market is rising. Consequently the existing market players are likelier to focus on expansion strategies besides product launches. Some of them are entering into strategic collaborations will other companies,” says the FMI Analyst.

Development of Effective and Compatible Sterilants to Meet the End Users’ Demand is A Key Strategy for Sterilants Market Players

The leading manufacturers are focusing on research and development to develop effective and compatible sterilants that can meet the end users’ demand. The current pandemic outbreak and the growing global demand for multifunctional sterilizing products have led the manufacturers to increase their research efforts and expand their product portfolio through innovative product launches. For instance, in 2020, in response to the pandemic situation of the coronavirus outbreak, Lanxess launched a high-level disinfectant named Rely+On Virkon.

Key Participant Insights

Some of the companies covered by FMI include 3M Company, Steris Plc., Cantel Medical Corporation, Evonik Industries AG, Arkema S.A., Thor Group, Metrex Research, LLC, Ecolab Inc., Solvay SA, LANXESS, Contec, Inc., OZU Corporation, Cetylite, Inc., Veltek Associates, Inc., Whiteley Corporation, Gul Biyoloji Laboratuvari, and others. These players are consolidating their positions through mergers, acquisitions and new product launches.  Besides this they are adopting various strategies to consolidate their market share.

For instance, in 2021, Steris Plc acquired Cantel, a global provider of infection prevention products and services primarily for endoscopy and dental customers, by entering into a definitive agreement through a U.S. subsidiary.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-13126

Want More Insights?

Future Market Insights (FMI) brings a comprehensive research report on forecast revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global sterilants market is segmented in detail to cover every aspect of the market and present a complete market intelligence report to the reader. The study provides compelling insights on the sterilants market on basis of product type such as ethylene oxide (EtO), glutaraldehyde, hydrogen peroxide gas plasma (HPGP), vaporized hydrogen peroxide, immersion and vapor phase peracetic acid and others. Based on form, sterilants are segmented into liquids and sprays. Based on end-users, the market is segmented into hospitals, clinics, ambulatory surgical centers, diagnostic laboratories, reference laboratories, rehabilitation centers, long-term care centers, critical care centers, pharmaceutical & biotechnology companies, academics and research institutes and homecare settings.

Sterilants Market by Category

Product

• Ethylene Oxide (EtO)
• Glutaraldehyde
• Hydrogen Peroxide Gas Plasma (HPGP)
• Vaporized Hydrogen Peroxide
• Immersion and Vapor Phase Peracetic Acid
• Others

Form

• Liquid
• Spray

End-user

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Diagnostic Laboratories
• Reference Laboratories
• Rehabilitation Centers
• Long Term Care Centers
• Critical Care Centers
• Pharmaceutical & Biotechnology Companies
• Academics and Research Institutes
• Homecare Settings

[240 Pages Report] A recent market study published by Future Market Insights (FMI) on the magnetic resonance imaging (MRI) contrast agents market offers global industry analysis for 2014-2018 and opportunity assessment for 2019-2029. The report consists of a comprehensive assessment of the most important market dynamics. On conducting thorough research on the historical as well as current growth parameters of the magnetic resonance imaging contrast agents market, growth prospects of the market are obtained with maximum precision.

The report features unique and salient factors that may make a huge impact on the development of the magnetic resonance imaging contrast agents market during the forecast period. It can help market players modify their manufacturing and marketing strategies to envisage maximum growth in the MRI contrast agents market in the coming years. The report provides detailed information about the current and future growth prospects of the magnetic resonance imaging contrast agents market in the most comprehensive way for better understanding of readers.

Data Points	Market Insights
Market Value 2022	U.S. $ 910.9 Mn
Market Value 2029	U.S. $ 1.23 Bn
CAGR 2022-2029	4.4%
Share of top 5 countries	60.8%

Download Sample Copy@ https://www.futuremarketinsights.com/reports/sample/rep-gb-11023

Magnetic Resonance Imaging (MRI) Contrast Agents Market : Segmentation

FMI’s study on the magnetic resonance imaging contrast agents market offers information divided into three important segments— product type, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

By Product

• Paramagnetic Contrast Agents
  • Extracellular Fluid (ECF) Agents
  • Blood Pool Contrast Agents (BPCAs)
  • Organ-specific Agents
• Superparamagnetic Contrast Agent

End User

• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Centers

Region

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• MEA

Ask an Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-11023

Chapter 1 – Executive Summary

The report commences with the executive summary of the MRI contrast agents market report, which includes the summary of key findings and statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the magnetic resonance imaging contrast agents market, as well as the key trends impacting the market.

Chapter 2 – Market Overview

Readers can find detailed taxonomy, definition of the magnetic resonance imaging contrast agents market, and the key inclusions and exclusions in this chapter, which help readers understand basic information about MRI contrast agents.

Chapter 3 – Key Market Trends

This section highlights the key trends impacting the magnetic resonance imaging contrast agents market, which will help readers understand the current trends and their impact on market growth.

Chapter 4 – Key Success Factors

In this chapter, the reader can get information about the parent market of MRI contrast agents market. Novel use cases, product adoption by region, product USPs, number of scans by country, and how combination imaging modalities will enhance medical imaging.

Chapter 5 – Global Magnetic Resonance Imaging Contrast Agents Market Volume (In Liters) Analysis 2014-2018 and Forecast, 2019-2029

This section explains the current and future market volume (In Liters) projections and the growth trend. Readers can also get knowledge the current installed base of MRI Units, by region/ country and historical market volume (In Liters) of global magnetic resonance imaging (MRI) contrast agents market.

Chapter 6 – Global Magnetic Resonance Imaging Contrast Agents Market – Pricing Analysis

The report covers the pricing analysis of the market on the basis of region and other attributes in this chapter. It will help the reader find comparative analysis of product pricing across different regions of the globe.

Buy Complete Report@ https://www.futuremarketinsights.com/checkout/11023

Chapter 7 – Global Magnetic Resonance Imaging Contrast Agents Market Value (US$) Analysis 2014-2018 and Forecast, 2019-2029

This section explains the global market value analysis and forecast for the MRI contrast agents market during the forecast period of 2019-2029. Along with the historical market and opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2019), and an incremental $ opportunity for the forecast period (2019–2029).

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

[322 Pages Report] According to a recent study done by Future Market Insights, the oxygen therapy equipment market is expected to reach US$ 6.4 Billion by 2032, up from US$ Oxygen Therapy Equipment Market billion in 2022, expanding at a high CAGR of 7.4%. This study explains that the Chronic respiratory diseases affect more than 1 billion people, globally, as per the Global Asthma report, 2018. COPD, with tobacco smoking as its root cause, has affected a significant part of the world population, as per the World Health Organization. These factors are expected to accelerate the growth of the Oxygen Therapy Equipment Market during the forecast period.

The advent of the technologically advanced oxygen source and delivery devices, which offers efficient patient care, is expected to boost the industry. These advancements include flow regulating devices, sensors, and conjunction of delivery devices with pulse dose meters. The adoption of O₂ therapy is increasing owing to the potential benefits such as controlled flow, efficient dosing, faster response rates, and greater durability & reliability. The aforementioned factors are anticipated to propel industry expansion.

Request a Sample of this Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-15011

In addition, rising popularity and adoption of on-demand and continuous Portable Oxygen Concentrators (POC) in a wide range of applications such as emergency medicine is also expected to fuel the demand in the forthcoming years. This surge is attributable to global competitors entering the market, demand for the portable technology by consumers, and the clinical urgency for greater mobility support for the geriatric population. The business is anticipated to increase owing to continuous innovation and resulting in more efficient units and reduced prices.

Increasing incidences of chronic respiratory diseases coupled with rising demand for home healthcare are the major drivers of the market. This can be ascribed to increasing geriatric population suffering from various kinds of chronic diseases in which oxygen therapy or oxygen support is required. Additionally, increasing levels of air pollution, smoking habits of population especially youth, among others have significantly contributed to an increase in the prevalence of respiratory diseases, thereby increasing the demand for oxygen therapy equipment.

As per the National Institutes of Health (NIH), nearly 12 million adults have been diagnosed with Chronic Obstructive Pulmonary Disease (COPD) in the U.S. and 120,000 people die each year. According to the data published by the Global Asthma Network (GAN), asthma affects nearly 334 million people worldwide.

North America dominates the oxygen therapy equipment market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the growing awareness about the benefits associated with oxygen therapy in hospitals and increasing number of end-users in this region.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-15011

Key Takeaways from the Market Study

• Global Oxygen Therapy Equipment Market was valued at US$ 3.1 Million by 2022-end
• The US to account for the highest value share of US$ 2.4 Billion of global market demand for Oxygen Therapy Equipment Market in 2032
• From 2015 to 2021, Oxygen Therapy Equipment demand expanded at a CAGR of 7%
• By Product, the Oxygen Source Equipment category constitutes the bulk of Oxygen Therapy Equipment Market with a CAGR of 2%.
• By Portability, the Stationary Devices segment dominates the Oxygen Therapy Equipment Market with a CAGR of 8%.

“The rising popularity and adoption of on-demand and continuous Portable Oxygen Concentrators (POC) in a wide range of applications such as emergency medicine is also expected to fuel the demand over the forecast period,” remarks an FMI analyst.

Competitive Landscape

Players in the global Oxygen Therapy Equipment Market focus on expanding their global reach through various strategies, such as; partnerships, collaborations, and partnerships. The players are also making a significant investment in R&D to add innovations to their products which would help them in strengthening their position in the global market. Some of the recent developments among the key players are:

• In July 2021, Belluscura (BELL) had signed a third distribution deal and first agreement with a durable medical equipment provider, for its X-PLO2R™ portable oxygen concentrator portfolio. The durable medical equipment (“DME”) has multiple stores in several states and an online store. Meanwhile, the third distributor has issued its first purchase order with anticipated delivery of the X-PLO2R™ portable oxygen concentrator expected in less than ninety days.
• In June 2020, Armstrong Medical introduced the second generation FD140i, an improved dual therapy flow driver with an easier transition from CPAP to HFOT.
• In August 2019, OxyGo LLC announced the launch of their new six flow setting, Bluetooth enabled POC. At only 4.7 pounds, and with 6 flow settings, the OxyGo NEXT offers the highest oxygen output per pound of weight of any portable oxygen concentrators currently on the market. Created to meet the needs of oxygen therapy patients and home medical equipment providers – for use at home, away, and for travel. OxyGo NEXT will allow healthcare providers to improve patient outcomes through a new wireless connectivity platform using Bluetooth technology.
• In October 2018, Resmed launched CPAP mask-Airlift f30i for Hospitals and Respiratory Care Physicians in the US.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-15011

Know More about What the Oxygen Therapy Equipment Market Repost Covers

Future Market Insights offers an unbiased analysis of the global Oxygen Therapy Equipment Market, providing historical data for 2015-2021 and forecast statistics from 2022-2032.

To understand opportunities in the Oxygen Therapy Equipment Market, the market is segmented on the basis of product, portability, and application across five major regions.

Key Players :

• Philips Healthcare
• Linde Healthcare
• Chart Industries, Inc.
• Invacare Corporation
• Becton, Dickinson and Company
• Smiths Medical
• Drägerwerk AG & Co. KGaA
• Teleflex Incorporated
• Fisher & Paykel Healthcare Corporation Limited
• Taiyo Nippon Sanso Corporation, Inogen, Inc.
• Heinen + Löwenstein GmbH & Co. KG
• DeVilbiss Healthcare
• Essex Industries, Inc.
• HERSILL, S.L.
• Weinmann Emergency Medical Technology GmbH + Co. KG
• Messer Medical Austria GmbH
• TECNO-GAZ S.p.A, HUM – Gesellschaft für Homecare und Medizintechnik mbH
• medicap homecare GmbH
• GCE Holding AB

Key Segments Covered in the Oxygen Therapy Equipment Market Report

Oxygen Therapy Equipment Market by Product:

• Oxygen Source Equipment
• Oxygen Therapy Equipment for Cardiovascular & Thoracic Surgeries
  • Oxygen Concentrators
  • Liquid Oxygen
  • Oxygen Cylinders
• Oxygen Delivery Devices
  • Oxygen Masks
  • Nasal Cannulas
  • Venturi Masks
  • Non-Rebreather Masks
  • Bag-Valve Masks
  • Other Oxygen Delivery Devices

Oxygen Therapy Equipment Market by Portability:

• Stationary Oxygen Therapy Equipment Devices
• Portable Oxygen Therapy Equipment Devices

Oxygen Therapy Equipment Market by Application:

• Oxygen Therapy Equipment for COPD
• Oxygen Therapy Equipment for Asthma
• Oxygen Therapy Equipment for Cystic Fibrosis
• Oxygen Therapy Equipment for Respiratory Distress Syndrome
• Oxygen Therapy Equipment for Pneumonia
• Oxygen Therapy Equipment for Other Diseases

Explore FMI’s Extensive ongoing Coverage on Healthcare Domain

Closed System Transfer Devices Market Trends : The global closed system transfer devices market is estimated to reach US$ 872 Mn in 2022, and anticipated to reach US$ 3800 Mn by 2032

Bone Cement Delivery Systems Market Outlook : The global bone cement delivery systems market is predicted to witness US$ 830 Mn in 2022 and is expected to exhibit a CAGR of 6.9% from 2022 to reach US$ 1730 Mn by 2032.

High flow Ventilators Market Demand : The High Flow Ventilators Market is expected to be worth USD 25 billion in 2021, USD 27 billion in 2022, and USD 67.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 10%.

Endoscopic Retrograde Cholangiopancreatography (ECRP) Devices Market Size : The global endoscopic retrograde cholangiopancreatography (ERCP) devices market is estimated to reach US$ 1.5 Bn in 2022

Elastography Imaging Market Share : The global elastography imaging market is estimated to reach US$ 3.1 Bn in 2022, and anticipated to reach US$ 8.9 Bn by 2032

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

According to the research report on global electronic trial master file (eTMF) market, it is expected to show exponential growth during the period of forecast, 2017-2027. The global market had witnessed high growth since the period 2012-2016 and this trend is likely to enhance in the coming years, till 2027. The global electronic trial master file (eTMF) market is estimated to reach a value more than US$ 190 Mn by the end of the assessment year from an estimate of US$ 51.7 Mn in 2017.

Future Market Insights has analysed numerous aspects of the electronic trial master file (eTMF) market and has included actionable insights in a systematic manner in its new research publication titled “Electronic Trial Master File (eTMF) Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)”. The extensive research study on eTMF market portrays various facets of the global market such as trends, opportunities, value chain analysis, competitive landscape, drivers, restraints and regional research along with key recommendations that can be viewed by the reader to achieve his/her strategic objectives in the long run.

Request a Sample Copy of this Report @
https://www.futuremarketinsights.com/reports/sample/rep-gb-1650

The research study also covers future market projections with respect to value for a period of ten years starting from 2017 till 2027. The comprehensive analysis of each segment and sub-segment of the global market portrays a real-time picture of the global market scenario.

Global Electronic Trial Master File (eTMF) Market: Segmental Highlights

In this research study, global electronic trial master file (eTMF) market is segmented by component, by deployment, by end user, by functionality and by region.

• By component, software segment is expected to lead the market in terms of value and is estimated to reach US$ 130.7 Mn by the end of the assessment year. The services segment in this category is projected to grow at the highest pace during 2017-2027
• By deployment, the cloud segment is highly lucrative and is adopted on a large scale. It is projected to grow at the fastest CAGR of 16.4% throughout the forecast period and is estimated to reach a noteworthy valuation by the end of the assessment year
• By end user, the Contract Research Organization (CRO) segment is anticipated to grow at a higher pace in the coming years to register a CAGR of 15.6% during the period of assessment
• By functionality, clinical operations segment is poised to dominate the market in terms of value and is estimated to reach a higher valuation of about US$ 970 Mn by the end of the assessment period. The auditing segment is projected to grow at a faster pace than other segments in the coming years
• By region, Asia Pacific excluding Japan (APEJ) is expected to show higher growth pace in the eTMF market whereas North America is likely to lead the market with a value a bit less than US$ 130 Mn by 2027 end

Asia Pacific excluding Japan to show high potential for growth in the electronic trial master file market

Several key players are focusing on the Asia Pacific excluding Japan (APEJ) region in order to tap the emerging economies in this region. The main advantage of this region is its high potential for growth as compared to matured economies. Several end use industries are showing interest in this region owing to which the supply side players are focusing their attention on APEJ to gain business expansion.

Electronic trial master file (eTMF) market in Asia Pacific excluding Japan (APEJ) region is expected to grow at the highest pace in the coming years to register a stellar CAGR of 17.6% and is estimated to reach a valuation of about US$ 18 Mn by the end of the period of assessment, thus becoming the third largest region in the eTMF market after Western Europe.

Global Electronic Trial Master File (eTMF) Market: Competitive Scenario

The research study includes a dedicated chapter on competitive scenario which deals with various key players involved in the eTMF market. Analysis on aspects such as SWOT analysis, geographical reach, strategies, product portfolio, expansion plans, mergers and acquisitions, key developments, distribution channel analysis etc., of the key players have been covered in this study. Companies like Veeva Systems, Medidata Solutions, Inc.,MasterControl, Inc.,Data Reduction Systems Corporation,Transperfect Global Inc., Aurea, Inc.,Phlexglobal Ltd., Arivis AG,Wingspan Technology Inc., and Montrium Inc.,are profiled in this section.

Market Segmentation

The research report on global electronic trial master file (eTMF) market includes weighted market segmentation that covers functionality, component, deployment mode, end user and region.

Before Buying, Visit for Customization @
https://www.futuremarketinsights.com/customization-available/rep-gb-1650

By Component

• Software
• Services

By Deployment

• On Premise
• Cloud

By End User

• Sponsors
• CRO
• Others

By Functionality

• Clinical Operations
• Records Management
• Auditing
• IT Operations

By Region

• North America
• Western Europe
• Eastern Europe
• APEJ
• Japan
• Latin America
• MEA

About Us

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights Inc.   
Christiana Corporate,
200 Continental Drive, 
Suite 401, Newark, 
Delaware – 19713, USA   
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Browse latest Market Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

As per Future Market Insights analysis, the global service integration and management market is estimated to reach a value of more than US$ 16.4 Bn by the end of 2027 from an estimate of a bit above US$ 6.7 Bn in 2017. It is expected to grow a high CAGR of 9.2% throughout the period of forecast, 2017-2027. The service integration and management market growth can be attributed to increasing deployment of IT and managed services.

Future Market Insights has undertaken comprehensive research on the service integration and management market and the deep dive in this sector has enabled FMI to surface new insights pertaining to the various trends, opportunities, drivers and restraints influencing the growth of the global service integration and management market Demand and also has included regional analysis, competitive scenario and future market projections in the “Service Integration and Management Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)” research report.

The analysis on each segment of the global market has made the research more fact-based and analytical giving in-depth foresight into the global market for service integration and management.

Request a Sample of this Report @
https://www.futuremarketinsights.com/reports/sample/rep-gb-4490

Global Service Integration and Management Market: Dynamics

Increasing expectations from users, increasing service targets, rise in multi-vendor and selective sourcing, rising supply network for delivery services, improvisation in IT performance, rising infrastructure services, increasing complexity of service management, rise in outsourcing of service integration, need for better IT delivery, rising customers and requirement changes and need for fast and seamless transition of new services have supported the growth of the global service integration and management market.

However, factors such as cultural gap, high cost of IT, challenges faced by small organizations, lack of key performance indicators, lack of proper implementation and challenges related to process and interface standards are interfering with the growth of the global service integration and management market.

Global Service Integration and Management Market: Forecast Projections

According to the fact based research report, the global service integration and management market is anticipated to grow at a meteoric growth rate to register a high CAGR of 9.2% during the period of forecast. The global service integration and management market is valued at about US$ 6.8 Bn in 2017 and is estimated to reach a valuation of more than US$ 16 Bn by the end of the assessment period.

Global Service Integration and Management Market: Segmental Highlights

The global service integration and management market is segmented by IT solutions, by enterprise type, by industry and by region.

• By region, the service integration and management market in Asia Pacific excluding Japan (APEJ) region is projected to grow at the highest pace in the coming years to register a CAGR of 13.0%. North America is considered to be an attractive and the largest market. The service integration and management market in North America is poised to reflect a higher value of more than US$ 5 Bn by 2027 end and thus expected to dominate the global market
• By IT solution type, the IT infrastructure management segment is the largest segment with respect to value and is poised to grow at a significant pace. The compliance and risk management segment is projected to be the fastest growing segment to register an exponential CAGR of 11.4% throughout the period of assessment
• By enterprise type, the small and medium enterprise segment is expected to gain high traction in the coming years and is poised to grow at a higher rate. The large enterprises segment is the largest and is estimated to reflect a higher market value of more than US$ 8.9 Bn by the end of the assessment year

Global Service Integration and Management Market: Key Players

The analytical research report on global service integration and management market has included profiling of key players involved in service integration and management. Key companies such as Capgemini, HCL Technologies Limited, Oracle Corporation, Wipro Limited, Fujitsu Limited, Cisco Systems, Inc., Accenture PLC, ATOS SE, ServiceNow Inc., Capita PLC, Tata Consultancy Services, CGI Group Inc., Quint Group, NTT Data Corporation, DXC technology and Sofigate Oy are included in this research report.

Feel free to Ask your Queries @
https://www.futuremarketinsights.com/ask-question/rep-gb-4490

Market Segmentation

By IT Solutions:

• IT Infrastructure Management
• Network Management
• Compliance & Risk Management
• Others

By Enterprise Type:

• Small & Medium Enterprise
• Large Enterprise

By Industry:

• IT & telecom
• BFSI
• Government
• Healthcare
• Oil & Gas and Energy
• Others

By Region:

• North America
• Western Europe
• Eastern Europe
• APEJ
• Japan
• Latin America
• MEA

About Us

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights Inc.   
Christiana Corporate,
200 Continental Drive, 
Suite 401, Newark, 
Delaware – 19713, USA   
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Browse latest Market Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs